Document Detail


Treatment of genetically obese mice with the iminosugar N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin reduces body weight by decreasing food intake and increasing fat oxidation.
MedLine Citation:
PMID:  21816446     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Obesity and its associated conditions such as type 2 diabetes mellitus are major causes of morbidity and mortality. The iminosugar N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin (AMP-DNM) improves insulin sensitivity in rodent models of insulin resistance and type 2 diabetes mellitus. In the current study, we characterized the impact of AMP-DNM on substrate oxidation patterns, food intake, and body weight gain in obese mice. Eight ob/ob mice treated with 100 mg/(kg d) AMP-DNM mixed in the food and 8 control ob/ob mice were placed in metabolic cages during the first, third, and fifth week of the experiment for measurement of substrate oxidation rates, energy expenditure, activity, and food intake. Mice were killed after 6 weeks of treatment. Initiation of treatment with AMP-DNM resulted in a rapid increase in fat oxidation by 129% (P = .05), a decrease in carbohydrate oxidation by 35% (P = .01), and a reduction in food intake by approximately 26% (P < .01) compared with control mice. Treatment with AMP-DNM decreased hepatic triglyceride content by 66% (P < .01) and, in line with the elevated fat oxidation rates, increased hepatic carnitine palmitoyl transferase 1a expression. Treatment with AMP-DNM increased plasma levels of the appetite-regulating peptide YY compared with control mice. Treatment with AMP-DNM rapidly reduces food intake and increases fat oxidation, resulting in improvement of the obese phenotype. These features of AMP-DNM, together with its insulin-sensitizing capacity, make it an attractive candidate drug for the treatment of obesity and its associated metabolic derangements.
Authors:
Mirjam Langeveld; Sjoerd A A van den Berg; Nora Bijl; Silvia Bijland; Cindy P van Roomen; Judith H Houben-Weerts; Roelof Ottenhoff; Sander M Houten; Ko Willems van Dijk; Johannes A Romijn; Albert K Groen; Johannes M Aerts; Peter J Voshol
Related Documents :
16172826 - Fiberoptic endoscopic evaluation of swallowing (fees) with and without blue-dyed food.
9578226 - Evaluation of chewing activity in the elderly person.
2589476 - Food transport through the anterior oral cavity in macaques.
15502356 - Effects of cross-sectional area on human bite studied with raw carrot and surimi gel.
499306 - Absorption of quinidine from an enteric-coated preparation.
2376546 - Comparative study of colorimetric dna hybridization method and conventional culture pro...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-8-2
Journal Detail:
Title:  Metabolism: clinical and experimental     Volume:  -     ISSN:  1532-8600     ISO Abbreviation:  -     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-8-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0375267     Medline TA:  Metabolism     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Affiliation:
Department of Medical Biochemistry, Academic Medical Center, 1105 AZ Amsterdam, the Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mitochondrial regulators of fatty acid metabolism reflect metabolic dysfunction in type 2 diabetes m...
Next Document:  Associations of urinary 6-sulfatoxymelatonin with biomarkers related to cardiovascular disease in Ja...